Tricyclic polyhydroxylic tyrosine kinase inhibitors

Details Tricyclic polyhydroxylic tyrosine kinase inhibitors Tricyclic polyhydroxylic tyrosine kinase inhibitors

C - Chemistry, Metallurgy

07

D

C07D 221/12 (2006.01) A61K 31/05 (2006.01) A61K 31/12 (2006.01) A61K 31/365 (2006.01) A61K 31/395 (2006.01) C07C 39/23 (2006.01) C07C 49/747 (2006.01) C07C 49/755 (2006.01) C07C 205/37 (2006.01) C07C 205/57 (2006.01) C07C 251/20 (2006.01) C07D 209/88 (2006.01) C07D 213/30 (2006.01) C07D 215/14 (2006.01) C07D 311/80 (2006.01) C07D 401/06 (2006.01)

Patent

CA 2108889

2108889 9221660 PCTABS00017 Certain tricyclic polyhydroxylic compounds, and their pharmaceutically-acceptable salts, are inhibitors of tyrosine kinase enzymes, and so are useful for the control of tyrosine kinase dependent diseases (e.g., cancer, atherosclerosis).

Affiliated with

Also associated with

Rating

Tricyclic polyhydroxylic tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic polyhydroxylic tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic polyhydroxylic tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1807620